ACTIVE

BIOMEDICAL SYSTEMS

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result594,1 k €+58,6 %over 1 year

Gross margin3,7 M €-6,6 %over 1 year

Equity9,1 M €+7,0 %over 1 year

Workforce22,3 ETP-19,8 %over 1 year

Identity

Source · BCE/KBO

BIOMEDICAL SYSTEMS is a Private limited company incorporated in 1981. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Leuven. It employs on average 22,3 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0421.984.741
Incorporation: 02/10/1981
Legal form: Private limited company
Registered office: Diestsepoort 1
3000 Leuven · FlandreSee on map
Contributed capital: 67 000,00 €
Latest accounts: 31/12/2025
Average workforce: 22,3 ETP

Activities (NACE)

72101Research and experimental development on natural sciences and engineering· main 72110Research and experimental development on biotechnology 85141Pre-primary education 86901Other human health activities 86910Other human health activities

Joint committees (3)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	3,7 M €	-6.6%	3,9 M €	-20.8%	5 M €	+5.8%	4,7 M €		–
EBITDA	855,7 k €	+48.5%	576,4 k €	-44.4%	1 M €	+17.6%	882 k €	+553%	-194,5 k €
Operating result	849,5 k €	+52.4%	557,5 k €	-42.8%	975 k €	+18.4%	823,5 k €	+374%	-300,3 k €
Net result	594,1 k €	+58.6%	374,6 k €	-52.1%	782,6 k €	+46.7%	533,3 k €	+284%	-290 k €
Balance sheet
Equity	9,1 M €	+7.0%	8,5 M €	+4.6%	8,1 M €	+10.7%	7,3 M €	+7.9%	6,8 M €
Total assets	11,2 M €	+5.9%	10,6 M €	+5.7%	10 M €	+4.4%	9,6 M €	+20.5%	8 M €
Cash	467,8 k €	-49.0%	918,1 k €	+27.4%	720,8 k €	+24.1%	580,8 k €	+338%	132,7 k €
Debts	2,2 M €	+1.6%	2,1 M €	+10.1%	1,9 M €	-15.4%	2,3 M €	+115%	1,1 M €
Other
Workforce	22,3 ETP	-19.8%	27,8 ETP	-20.1%	34,8 ETP	-6.5%	37,2 ETP	-2.6%	38,2 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 11 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Timothy COBB	Directorsince 18/11/2024
Jason KNOBLAUCH	Directorsince 07/08/2023
Christopher FIKRY	Directorsince 01/07/2022

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Michael BONELLO	Director01/07/2022 → 07/08/2023
Joseph F. EAZOR	Director02/10/2020 → 2020 accounts
Tom VADAKETH	Director01/02/2020 → 2020 accounts

Other companies at this address

Diestsepoort 1 3000 Leuven

Company	CBE no.
ArtiQ● Active	0720.636.061
EverESSt● Active	1007.726.763
HYP3● Active	0899.235.629
LVL7● Active	0675.346.266
VITAMINS@WORK● Active	0783.584.113

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	07/07/2026	01/07/2025	29/08/2024	14/06/2023	01/09/2022	25/08/2021
General meeting	05/06/2026	04/06/2025	05/06/2024	14/06/2023	01/07/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	05/06/2026	07/07/2026	Dutch	PDF
Abridged model	31/12/2024	04/06/2025	01/07/2025	Dutch	PDF
Abridged model	31/12/2023	05/06/2024	29/08/2024	French	PDF
Abridged model	31/12/2022	14/06/2023	14/06/2023	French	PDF
Full model	31/12/2021	01/07/2022	01/09/2022	French	PDF
Full model	31/12/2020	30/06/2021	25/08/2021	French	PDF
Full model	31/12/2019	15/07/2020	04/08/2020	French	PDF
Full model	31/12/2018	28/06/2019	21/08/2019	French	PDF
Full model	31/12/2017	29/06/2018	23/08/2018	French	PDF
Full model	31/12/2016	30/06/2017	18/07/2017	French	PDF
Full model	31/12/2015	30/06/2016	30/06/2016	French	PDF
Full model	31/12/2014	22/06/2015	29/06/2015	French	PDF
Full model	31/12/2013	04/06/2014	18/11/2014	French	PDF
Full model	31/12/2012	28/06/2013	23/07/2013	French	PDF
Full model	31/12/2011	06/06/2012	12/06/2012	French	PDF
Full model	31/12/2010	30/06/2011	02/08/2011	French	PDF
Full model	31/12/2009	30/06/2010	20/07/2010	French	PDF
Full model	31/12/2008	30/06/2009	31/07/2009	French	PDF
Full model	31/12/2007	03/03/2008	13/06/2008	French	PDF
Full model	31/12/2006	06/06/2007	24/07/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 11 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Timothy COBB	Directorsince 18/11/2024
Jason KNOBLAUCH	Directorsince 07/08/2023
Christopher FIKRY	Directorsince 01/07/2022

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Michael BONELLO	Director01/07/2022 → 07/08/2023
Joseph F. EAZOR	Director02/10/2020 → 2020 accounts
Tom VADAKETH	Director01/02/2020 → 2020 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates20/12/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/10/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/10/2024
DEMISSIONS, NOMINATIONS - DIVERS
PDF
Mandates12/02/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates13/09/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates28/12/2022
SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF
Mandates28/12/2022
MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/08/2021
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings20 filings

Mandates

Timothy COBB

Jason KNOBLAUCH

Christopher FIKRY

Michael BONELLO

Joseph F. EAZOR

Tom VADAKETH

James Michael CORRIGAN

Waqar NASIM

Raymond Barrett

Timothy R. Barrett

Thimothy R. BARRETT

Timothy Raymond BARRETT

Show the 2 other mandates

1981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026

BIOMEDICAL SYSTEMS

Diestsepoort 1, 3000 LeuvenAvenue Hermann Debroux 54, 1160 Auderghem

Director

DirectorManager

ManagerDirector

Manager

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Diestsepoort 1, 3000 LeuvenCurrent	accounts 2024 → 2025	Accounts 2025 · 2026-00267614
Avenue Hermann Debroux 54, 1160 Auderghem	accounts 2022 → 2023	Accounts 2023 · 2024-00434787
CHAUSSEE DE WAVRE 1945, 1160 Auderghem	accounts 2021	Accounts 2021 · 2022-20409409

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
BIOMEDICAL SYSTEMSCurrent	accounts 2006 → 2025	Accounts 2025 · 2026-00267614

Events

2025
Annual accounts 2025594,1 k €↑
2024
Annual accounts 2024374,6 k €↓
2023
Annual accounts 2023782,6 k €↑
2022
Annual accounts 2022533,3 k €↑
2021
Annual accounts 2021-290 k €↓
2020
Annual accounts 20209,7 k €↓
2019
Annual accounts 2019980,9 k €↑
2018
Annual accounts 2018370,9 k €↓
2017
Annual accounts 20172,1 M €↑
2016
Annual accounts 201617,4 k €↑
2015
Annual accounts 2015-196,4 k €↑
2014
Annual accounts 2014-1,2 M €↓
2013
Annual accounts 20135,5 k €↓
2012
Annual accounts 2012323 k €↓
2011
Annual accounts 2011633,3 k €↑
2010
Annual accounts 2010-157,6 k €↓
2009
Annual accounts 2009-31,1 k €↑
2008
Annual accounts 2008-752,3 k €↓
2007
Annual accounts 20071 M €↑
2006
Annual accounts 2006701 k €
02/10/1981
IncorporationPrivate limited company

BIOMEDICAL SYSTEMS

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events